PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.
about
Inhibition of COX-2/PGE2 cascade ameliorates cisplatin-induced mesangial cell apoptosis.Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction.Microsomal prostaglandin E2 synthase-1 inhibitors: a patent review.PGE2 EP1 receptor inhibits vasopressin-dependent water reabsorption and sodium transport in mouse collecting duct.FADS1-FADS2 genetic polymorphisms are associated with fatty acid metabolism through changes in DNA methylation and gene expression
P2860
PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.
@ast
PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.
@en
type
label
PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.
@ast
PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.
@en
prefLabel
PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.
@ast
PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.
@en
P2093
P2860
P356
P1476
PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.
@en
P2093
Ramzi Hassouneh
Rania Nasrallah
Richard L Hébert
P2860
P304
P356
10.1681/ASN.2015050528
P577
2015-08-28T00:00:00Z